Top 50 Clinical Trial Platform

The startup operates a clinical trial data platform that integrates licensed healthcare professionals with connected technology to facilitate decentralized clinical trials. This approach enhances trial accessibility and efficiency, allowing patients to consult with doctors and enabling continuous patient monitoring outside traditional clinical settings.

Medable provides a digital platform for decentralized clinical trials that utilizes patient-generated data to enhance participant recruitment and streamline data collection. By integrating tools for remote scheduling, consent management, and real-time reporting, the platform improves the efficiency and quality of clinical research across over 60 countries.

Macro Trials is a precision research clinical platform that utilizes a digitally powered infrastructure and a hub-and-spoke distributed model to enhance the efficiency of clinical trials for high-value therapeutics. The platform addresses the challenges of patient recruitment and administrative burdens for clinicians, enabling diverse candidate access and streamlined participation in groundbreaking research.

Paradigm is developing a platform that integrates clinical trial management systems to enhance trial efficiency and reduce participation barriers for both patients and healthcare providers. By creating a unified infrastructure, Paradigm aims to provide equitable access to clinical trials, accelerating the delivery of potentially life-saving therapies.

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

Faro Health provides an AI-enabled platform for designing and implementing clinical trial protocols, streamlining the complexities of protocol development through data-driven insights and reusable content. This technology reduces authoring time and enhances the quality of clinical trials, minimizing patient burden and associated costs.

PhaseV develops a machine learning-based platform that utilizes causal inference and multi-arm bandit algorithms to optimize adaptive clinical trial design and execution. This technology enhances decision-making and resource allocation, increasing the success rates of clinical trials by providing real-time, data-driven insights throughout the trial process.

ObvioHealth offers the ObvioGo® 2.0 platform, which utilizes digital tools for real-time data capture and participant engagement in clinical trials. This technology addresses inefficiencies in traditional trial management by providing customizable study designs and enhancing data accuracy, resulting in faster recruitment and improved compliance.

OneStudyTeam offers the StudyTeam platform, a cloud-based solution that digitizes clinical trial site workflows to enhance patient recruitment and enrollment efficiency. By providing real-time visibility into recruitment activities, the platform reduces administrative burdens on research sites and enables sponsors to optimize patient enrollment strategies.

Power Life Science is a platform that connects patients with over 30,000 active clinical trials, allowing them to filter options based on specific medical conditions, locations, and drug types. This service addresses the challenge of limited access to experimental treatments by streamlining the search process and facilitating direct connections with researchers.

Medidata provides a cloud‑based platform that consolidates study configuration, electronic data capture, trial management, and patient‑engagement tools for pharmaceutical, biotech, device sponsors and CROs. The SaaS solution uses AI‑driven analytics to automate data cleaning, risk‑based monitoring, and real‑world data linkage, while supporting decentralized trial workflows such as eConsent, eCOA and wearable sensor integration. Open APIs connect to eTMF, CTMS and synthetic control arms, enabling faster, compliant study execution.

Medrio provides a cloud‑based, no‑code platform that integrates electronic data capture, randomization and trial supply management, ePRO and eConsent into a single validated solution. The system enables sponsors and CROs to configure and launch studies in weeks, apply mid‑study amendments without downtime, and maintain real‑time, audit‑ready data across sites. Built‑in ISO 9001, GDPR and 21 CFR Part 11 compliance and 24/7 support help reduce operational costs and accelerate trial timelines.

This startup provides a platform that offers patients intuitively accessible, understandable, complete, up-to-date, and engaging information on clinical trials in Europe. It aims to bridge the gap between patients and clinical research opportunities.

Florence Healthcare provides a Site Enablement Platform that automates document workflows and participant enrollment for clinical trials, enhancing collaboration among sponsors, CROs, and research sites. By connecting over 20,000 research sites globally, the platform streamlines clinical research processes, reducing operational risks and accelerating trial timelines.

Verisian offers a platform for clinical trial analysis that replaces manual double programming with Full Study Traceability. It accelerates submissions and approvals by mapping dependencies between specifications, code, and data, while AI co-pilots assist with code generation and documentation.

Akkure is a digital platform utilizing AI and genomics to enhance clinical trial recruitment for oncology by providing precise patient-trial matching and personalized trial recommendations. The platform ensures GDPR and HIPAA compliance, facilitating secure access and ownership of clinical data while streamlining the enrollment process for patients and healthcare providers.

TRYAL is an AI-enabled platform that transforms clinical study protocols into structured data, automating the creation of essential systems and documents needed for clinical trials. This technology significantly reduces the time and resources required for study startup, enhancing enrollment and data capture processes while ensuring regulatory compliance.

This AI-powered platform automates patient identification and recruitment for clinical trials by integrating with electronic health records. It helps research sites accelerate enrollment, reduce screen failures, and improve operational efficiency, ultimately speeding up the development of new therapies.

The startup has developed a healthcare technology platform that connects patients with eligible clinical trials, facilitating direct communication between patients and pharmaceutical companies. This platform enhances patient engagement and ensures that health information is effectively shared with medical professionals, improving trial participation and patient understanding of health outcomes.

Evrima provides a technology-driven platform that enhances the recruitment process for clinical trials by efficiently connecting diverse participants with researchers and clinicians. This approach addresses the significant delays in trial recruitment, enabling faster patient enrollment and improved health outcomes.

Themison is a patient-centric platform that utilizes real-time engagement analytics and a mobile app to enhance communication and support throughout clinical trials. By simplifying complex medical information and personalizing patient experiences, the platform aims to reduce dropout rates and accelerate trial completion.

Signant Health provides a unified eClinical platform that integrates electronic Clinical Outcome Assessments (eCOA), electronic consent (eConsent), and Interactive Response Technology (IRT) to enhance data collection and management in clinical trials. This technology addresses the challenge of obtaining reliable, high-quality trial data from diverse patient populations and sites, ensuring efficient and accurate regulatory submissions.

This clinical trials platform provides a comprehensive suite of tools for pharmaceutical, biotech, and CRO clients, streamlining workflows from consent management and televisit scheduling to patient data collection. It enhances participant engagement and offers operational dashboards for study control, leveraging distributed computing for global accessibility.

The startup operates a cloud-based platform that facilitates the management of pharmaceutical clinical trials through integrated planning, outsourcing, and financial contract management. By providing detailed insights and analytics on clinical portfolios and provider performance, the platform enhances operational efficiency and decision-making for businesses in the pharmaceutical sector.

Provides a HIPAA-compliant platform that integrates with electronic health records (EHR) to automate patient pre-screening and recruitment for clinical trials. By leveraging AI-driven patient matching and site management partnerships, it reduces enrollment delays, increases trial accessibility for rural and community-based providers, and enables real-time monitoring of recruitment progress for sponsors.

The startup operates an online medical platform that enhances community engagement in clinical trial education and patient recruitment through targeted outreach and support for nonprofit organizations. By increasing enrollment in clinical trials, the platform enables diverse participation in medical studies, ultimately improving healthcare outcomes.

Aparito's Atom5™ eCOA platform digitizes clinical trials by capturing high-frequency data through video assessments, wearable devices, and electronic patient-reported outcomes (ePROs). This technology enables clinical teams to obtain real-time insights from real-world data, enhancing the efficiency and accuracy of trial monitoring.

RealTime offers a cloud‑native eClinical SaaS that combines a Clinical Trial Management System with electronic regulatory, source, and consent modules, plus participant engagement and digital payment tools. The platform provides real‑time data synchronization, API‑first integration with EDC, ERP and analytics systems, and built‑in analytics dashboards, while meeting 21 CFR Part 11 and GDPR compliance for sites, CROs and sponsors.

EvidentIQ provides an integrated cloud platform for clinical data management, featuring electronic data capture (EDC), clinical trial management systems (CTMS), and electronic trial master files (eTMF) to streamline decentralized clinical trials. The platform enhances patient engagement and data reliability, addressing inefficiencies in clinical research processes and improving the accuracy of patient-centered outcomes.

Tilda Sense is an AI-powered workflow automation platform designed for clinical trial management. It integrates with existing clinical software to automate routine tasks, optimize collaboration, and provide real-time insights for sponsors, sites, and CROs, significantly reducing time and cost in study management, setup, and closeout.

Carebox Connect is a platform that matches patients, families, and physicians with clinical trial opportunities tailored to specific diagnoses and treatment histories, streamlining the search process. By addressing the low participation rates in clinical trials, Carebox enhances patient access to potentially life-saving treatments while improving recruitment efficiency for trial sponsors.

Uses AI-powered algorithms to analyze electronic health records and genomic data, rapidly matching cancer patients to suitable clinical trials in minutes. This platform streamlines the trial recruitment process by integrating with EHR systems and genomic databases, reducing the time and cost associated with manual matching. By providing precise, personalized trial recommendations, it expands treatment options and accelerates medical research globally.

WeTrials is a platform that simplifies access to clinical trials by providing personalized treatment options and educational resources tailored to patients' specific health needs. The platform enhances patient engagement and decision-making by offering streamlined enrollment processes and expert guidance throughout the healthcare journey.

The startup operates a patient-matching platform that connects individuals with similar health conditions to clinical trials, enhancing participant recruitment for medical research. By providing pharmaceutical companies and research institutions access to a diverse pool of engaged patients, the platform accelerates the pace of clinical studies and improves trial outcomes.

Clinical Trial Bid is an AI-enhanced platform that connects clinical trial sponsors with over 4,500 service providers by generating tailored RFPs and facilitating accurate proposal submissions. This streamlines the vendor selection process, reducing the time from RFP to proposal from months to under ten days.

ClinEco is a web-based platform that connects sponsors, contract research organizations (CROs), and clinical trial sites, facilitating the selection of partners and resources for clinical research. By providing a centralized marketplace, ClinEco addresses the inefficiencies in vendor selection and collaboration, enabling stakeholders to streamline their clinical trial processes and enhance operational efficiency.

Castor provides a cloud-based clinical data platform that integrates electronic data capture (EDC), electronic patient-reported outcomes (ePRO), and electronic consent (eConsent) to facilitate decentralized clinical trials. This platform enables researchers to efficiently collect, manage, and analyze data from multiple sources while ensuring compliance with regulatory standards, ultimately reducing the time and complexity of clinical trial processes.

Ethica provides a cloud-based platform for managing clinical trials, centralizing documentation and data to improve collaboration and operational efficiency. Its features support protocol development, site management, and data monitoring, helping research teams streamline drug development and maintain regulatory compliance.

Curewiki provides a secure platform that utilizes artificial intelligence to match patients with relevant clinical trials from a database of over 24,000 validated studies. This service addresses the challenge of patients missing out on potentially life-saving treatment opportunities by facilitating easy access to trial information tailored to their specific health profiles.

Veda offers a platform that expands clinical trial access by enabling doctors in local communities to conduct research. This broader reach helps biopharma companies accelerate enrollment, reduce trial costs, and bring new therapies to market faster.

Almara is a health tech startup that utilizes an AI-driven algorithm to match patients with clinical trials based on their medical history, genetics, and preferences, ensuring personalized trial connections. The platform addresses healthcare disparities by enhancing access to clinical trials for underprivileged communities, streamlining the trial process and reducing administrative burdens for both patients and organizers.

PHARMASEAL is developing the Engility® platform, a cloud-based clinical trial management system that integrates trial and document management to enhance oversight and collaboration among biopharmaceutical companies. This platform addresses inefficiencies in trial execution by providing real-time intelligence and rapid implementation, reducing costs and risks associated with clinical trials.

DragOnFlow is a Protocol Excellence Execution Platform that transforms complex clinical trial protocols into interactive guides, enhancing protocol adherence and minimizing errors. By providing real-time data collection and comprehensive reporting, it ensures data integrity and patient safety while accelerating trial timelines and reducing operational costs.

Triall provides a blockchain-integrated eClinical platform that offers customizable software solutions for the entire clinical trial lifecycle, including study design, execution, and post-study analysis. By leveraging interoperable technologies and a network of specialized CRO partners, Triall enhances data integrity and operational efficiency in clinical research.

This startup connects patients and doctors to clinical trials through an accessible platform. It aims to accelerate medical research by streamlining patient recruitment and trial participation, ultimately enhancing patient outcomes and advancing medical knowledge.

Tectonic combines AI-driven automation with a robust operational platform to enhance the efficiency of clinical trial management. The platform addresses inefficiencies in clinical operations by streamlining data integration and workflow processes, ultimately reducing time and costs associated with trial execution.

The startup offers a clinical trials data platform that connects researchers with suitable trials and automates candidate scheduling and rescheduling management. This platform minimizes participant dropouts through regular follow-ups and reminders, enabling researchers to effectively track progress and communicate with clinicians.

The startup offers a clinical trials data platform that enables keyword searches for trial designs, researchers, and results, along with clinical trend reports categorized by disease, drug, region, and institution. This platform helps companies minimize the time and costs associated with conducting clinical trials by providing high-scored contract research organization (CRO) recommendations based on digital requests for proposals.

MyTrials.ai provides a platform that connects patients with relevant clinical trials by simplifying the search process through user-friendly interfaces and clear information. This addresses the challenge of patient access to clinical trials, which is often hindered by complex medical terminology and procedural barriers.

Concinnity Company provides Cloud Concinnity®, a secure cloud-based platform for clinical trial oversight that facilitates rapid data access and real-time communication among oversight committees. This technology addresses inefficiencies in clinical trial management by streamlining processes, enhancing collaboration, and improving patient safety while reducing time to market for treatments.